Explore
Validate
Learn14560-1-AP
antibody from Proteintech Group
Targeting: DHRS9
3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14560-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14560-1-AP, RRID:AB_2277277
- Product name
- DHRS9 antibody
- Antibody type
- Polyclonal
- Description
- DHRS9 antibody (Cat. #14560-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Immune-related biomarkers for major depressive disorder identified via integrated bioinformatics and machine learning.
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival.
Identifying potential signatures for atherosclerosis in the context of predictive, preventive, and personalized medicine using integrative bioinformatics approaches and machine-learning strategies.
Identification of Proteomic Signatures in Chronic Obstructive Pulmonary Disease Emphysematous Phenotype.
Zhang Y, Wu P, Nie Z, Liu Z
European journal of psychotraumatology 2026 Dec;17(1):2619389
European journal of psychotraumatology 2026 Dec;17(1):2619389
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival.
Irmer B, Wlochowitz D, Krekeler C, Richter KM, Chandrabalan S, Bayerlova M, Wolff A, Lenz G, Conradi LC, Schildhaus HU, Stadelmann C, Rohde V, Proescholdt M, Salinas G, Homayounfar K, Kuhlmann T, Hailfinger S, Pukrop T, Menck K, Beissbarth T, Bleckmann A
Molecular oncology 2025 Mar;19(3):614-634
Molecular oncology 2025 Mar;19(3):614-634
Identifying potential signatures for atherosclerosis in the context of predictive, preventive, and personalized medicine using integrative bioinformatics approaches and machine-learning strategies.
Xu J, Zhou H, Cheng Y, Xiang G
The EPMA journal 2022 Sep;13(3):433-449
The EPMA journal 2022 Sep;13(3):433-449
Identification of Proteomic Signatures in Chronic Obstructive Pulmonary Disease Emphysematous Phenotype.
Bai S, Ye R, Wang C, Sun P, Wang D, Yue Y, Wang H, Wu S, Yu M, Xi S, Zhao L
Frontiers in molecular biosciences 2021;8:650604
Frontiers in molecular biosciences 2021;8:650604
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The DHRS9 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human DHRS9. This antibody recognizes human, mouse, rat antigen. The DHRS9 antibody has been validated for the following applications: ELISA, WB analysis.
